東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Evaluation of β- and α/β-peptides as...

Rodriguez Lopez, Angelica de L.

FindBook

Google Book

Amazon

博客來

Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms./
作者:	Rodriguez Lopez, Angelica de L.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	163 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
Contained By:	Dissertations Abstracts International80-08B.
標題:	Bioengineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13427689
ISBN:	9780438842762

Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms.
Rodriguez Lopez, Angelica de L.

Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 163 p.

Source: Dissertations Abstracts International, Volume: 80-08, Section: B.

Thesis (Ph.D.)--The University of Wisconsin - Madison, 2019.

This item must not be sold to any third party vendors.

The work included in this thesis is motivated by the current clinical need for developing new antimicrobial strategies to prevent biofilm-related microbial infections. Here, we first describe our work on evaluating the use of anti-virulence small-molecules for developing combinatorial strategies that reduced the concentrations needed of β-peptidomimetics of antimicrobial α-peptides to prevent C. albicans biofilms (Chapter 2). We identified that combinations with isoamyl alcohol, a C. albicans autoregulatory molecule, improved β-peptide activity by up to 128-fold while causing less than 10% mammalian cell toxicity at concentrations that prevented biofilms. We also evaluated β-peptides effectiveness for preventing clinically-relevant polymicrobial biofilms (Chapter 3). We identified that similar β-peptide concentrations were required for preventing in vitro S. aureus (SA) - C. albicans (CA) polymicrobial biofilms as for preventing monomicrobial biofilms, independently of the containing ratios of S. aureus and C. albicans cells. Furthermore, we demonstrate the prevention of SA-CA polymicrobial biofilms from catheter tube segments by using thin-film-based polymeric coatings embedded with β-peptide. These studies motivate the work performed in the second section directed towards demonstrating the use of β- and α/β-peptide containing polymeric multilayer-based materials for the development of prophylactic strategies to prevent bacterial (Chapter 4) and fungal (Chapter 5) biofilms from titanium and catheter tube surfaces, as prototypes of medical devices susceptible to biofilm-related infections. We used layer-by-layer techniques for the fabrication of β-peptide-containing chitosan and hyaluronic acid thin-films on rough titanium surfaces and our antimicrobial activity results demonstrate we can tune β-peptide loading, by varying β-peptide concentration in loading solutions, to achieve the release β-peptides quantities that prevented S. aureus biofilms but were benign to mammalian cells with osteogenic potential (Chapter 4). Finally, we then describe an approach consisting of poly-L-glutamic acid and poly-L-lysine multilayers for the localized and controlled release of α/β-peptides from catheter surfaces to selectively prevent C. albicans biofilms in vitro and in vivo (Chapter 5). Overall, these studies motivated further development of β- and α/β-peptides as novel antimicrobials and demonstrate the use of materials-based approaches for fabricating antimicrobial coatings on medical devices prone to biofilm-associated infections that could potentially reduce the clinical incidence of microbial infections.

ISBN: 9780438842762Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

Antimicrobial peptides

Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms.
LDR:03937nmm a2200397 4500 001 2270362
005 20200929060906.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9780438842762
035 $a (MiAaPQ)AAI13427689
035 $a (MiAaPQ)wisc:15998
035 $a AAI13427689
040 $a MiAaPQ $c MiAaPQ
100 1 $a Rodriguez Lopez, Angelica de L. $3 3547734
245 1 0 $a Evaluation of β- and α/β-peptides as Novel Antimicrobial Agents for Preventing Microbial Biofilms.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 163 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Palecek, Sean P.
502 $a Thesis (Ph.D.)--The University of Wisconsin - Madison, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a The work included in this thesis is motivated by the current clinical need for developing new antimicrobial strategies to prevent biofilm-related microbial infections. Here, we first describe our work on evaluating the use of anti-virulence small-molecules for developing combinatorial strategies that reduced the concentrations needed of β-peptidomimetics of antimicrobial α-peptides to prevent C. albicans biofilms (Chapter 2). We identified that combinations with isoamyl alcohol, a C. albicans autoregulatory molecule, improved β-peptide activity by up to 128-fold while causing less than 10% mammalian cell toxicity at concentrations that prevented biofilms. We also evaluated β-peptides effectiveness for preventing clinically-relevant polymicrobial biofilms (Chapter 3). We identified that similar β-peptide concentrations were required for preventing in vitro S. aureus (SA) - C. albicans (CA) polymicrobial biofilms as for preventing monomicrobial biofilms, independently of the containing ratios of S. aureus and C. albicans cells. Furthermore, we demonstrate the prevention of SA-CA polymicrobial biofilms from catheter tube segments by using thin-film-based polymeric coatings embedded with β-peptide. These studies motivate the work performed in the second section directed towards demonstrating the use of β- and α/β-peptide containing polymeric multilayer-based materials for the development of prophylactic strategies to prevent bacterial (Chapter 4) and fungal (Chapter 5) biofilms from titanium and catheter tube surfaces, as prototypes of medical devices susceptible to biofilm-related infections. We used layer-by-layer techniques for the fabrication of β-peptide-containing chitosan and hyaluronic acid thin-films on rough titanium surfaces and our antimicrobial activity results demonstrate we can tune β-peptide loading, by varying β-peptide concentration in loading solutions, to achieve the release β-peptides quantities that prevented S. aureus biofilms but were benign to mammalian cells with osteogenic potential (Chapter 4). Finally, we then describe an approach consisting of poly-L-glutamic acid and poly-L-lysine multilayers for the localized and controlled release of α/β-peptides from catheter surfaces to selectively prevent C. albicans biofilms in vitro and in vivo (Chapter 5). Overall, these studies motivated further development of β- and α/β-peptides as novel antimicrobials and demonstrate the use of materials-based approaches for fabricating antimicrobial coatings on medical devices prone to biofilm-associated infections that could potentially reduce the clinical incidence of microbial infections.
590 $a School code: 0262.
650 4 $a Bioengineering. $3 657580
650 4 $a Microbiology. $3 536250
650 4 $a Engineering. $3 586835
653 $a Antimicrobial peptides
653 $a Biofilms
653 $a C. albicans
653 $a S. aureus
653 $a Thin-films
690 $a 0202
690 $a 0410
690 $a 0537
710 2 $a The University of Wisconsin - Madison. $b Materials Science. $3 2106447
773 0 $t Dissertations Abstracts International $g 80-08B.
790 $a 0262
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13427689